DooDiligence Posted April 28, 2017 Share Posted April 28, 2017 http://catalyst.nejm.org/is-value-based-drug-pricing-compatible-with-pharma-innovation/ The part about enabling payers to migrate the costs of care when the patients themselves move & the burden on payers to manage this risk is interesting... Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now